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Cellular/Molecular

Chimeric Glutamate Receptor Subunits Reveal the
Transmembrane Domain Is Sufficient for NMDA Receptor
Pore Properties but Some Positive Allosteric Modulators
Require Additional Domains
Timothy J. Wilding, Melany N. Lopez, and XJames E. Huettner
Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110

NMDA receptors are ligand-gated ion channels that underlie transmission at excitatory synapses and play an important role in regulating
synaptic strength and stability. Functional NMDA receptors require two copies of the GluN1 subunit coassembled with GluN2 (and/or
GluN3) subunits into a heteromeric tetramer. A diverse array of allosteric modulators can upregulate or downregulate NMDA receptor
activity. These modulators include both synthetic compounds and endogenous modulators, such as cis-unsaturated fatty acids, 24(S)hydroxycholesterol, and various neurosteroids. To evaluate the structural requirements for the formation and allosteric modulation of
NMDA receptor pores, we have replaced portions of the rat GluN1, GluN2A, and GluN2B subunits with homologous segments from the rat
GluK2 kainate receptor subunit. Our results with these chimeric constructs show that the NMDA receptor transmembrane domain is
sufficient to account for most pore properties, but that regulation by some allosteric modulators requires additional cytoplasmic or
extracellular domains.
Key words: carboxy terminal domain; docosahexaenoic acid; palmitoylation

Significance Statement
Glutamate receptors mediate excitatory synaptic transmission by forming cation channels through the membrane that open upon
glutamate binding. Although many compounds have been identified that regulate glutamate receptor activity, in most cases the
detailed mechanisms that underlie modulation are poorly understood. To identify what parts of the receptor are essential for pore
formation and sensitivity to allosteric modulators, we generated chimeric subunits that combined segments from NMDA and
kainate receptors, subtypes with distinct pharmacological profiles. Surprisingly, our results identify separate domain requirements for allosteric potentiation of NMDA receptor pores by pregnenolone sulfate, 24(S)-hydroxycholesterol, and docosahexaenoic acid, three endogenous modulators derived from membrane constituents. Understanding where and how these
compounds act on NMDA receptors should aid in designing better therapeutic agents.

Introduction
Vertebrate central neurons express multiple receptors for the excitatory neurotransmitter L-glutamate, including three different
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families of ionotropic receptors (iGluRs) named for the agonists
NMDA, AMPA, and kainate (Traynelis et al., 2010). Distinct sets
of subunits, with limited primary sequence identity, contribute to
these three iGluR families (Traynelis et al., 2010), but they all
share a similar modular organization that includes large extracellular amino-terminal and ligand-binding domains (ATDs and
LBDs), a transmembrane domain (TMD) that forms the channel
pore (Huettner, 2015), and a cytoplasmic carboxy terminal domain (CTD; Sobolevsky et al., 2009; Karakas and Furukawa,
2014; Lee et al., 2014). Functional iGluRs are tetramers that, in
the case of NMDA receptors, require two GluN1 subunits com-
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bined in a heterotetramer with GluN2
and/or GluN3 subunits, of which there
are four (GluN2A–GluN2D) and two
(GluN3A and GluN3B) subtypes, respectively (Paoletti et al., 2013). Additional diversity arises from alternate splicing of
GluN1 and post-translational modifications, including phosphorylation and palmitoylation of specific residues in the
subunit CTDs (Collingridge et al., 2013).
Conventional NMDA receptors, made
up of GluN1 and GluN2 subunits, require
coactivation by glutamate, which binds to
the GluN2 subunit, and glycine or
D-serine, which bind to GluN1 (Traynelis
et al., 2010). This subunit combination
forms channels that exhibit voltagedependent block by magnesium but high
permeability to monovalent cations and
calcium. Because calcium entry through
the channels requires both presynaptic
transmitter release and postsynaptic depolarization to remove magnesium block,
this unique permeation profile underlies
the ability of NMDA receptors to regulate
plasticity at excitatory synapses by detecting coincidence of presynaptic and postsynaptic activity (Paoletti et al., 2013).
NMDA receptors are subject to regulation by a wide variety of different
compounds (Traynelis et al., 2010; Collingridge et al., 2013; Zhu and Paoletti,
2015), including several endogenous
modulators derived from constituents of
the plasma membrane. Both ⍀-6 and ⍀-3
cis-unsaturated fatty acids, such as arachidonic acid (AA) and docosahexaenoic
acid (DHA), potentiate neuronal and recombinant NMDA receptors (Miller et
al., 1992; Nishikawa et al., 1994), whereas
lysophospholipids are inhibitory (Casado
and Ascher, 1998). In addition, a number
of endogenous steroid compounds, including neurosteroids (Gibbs et al., 2006;
Korinek et al., 2011) and cholesterol metabolites (Paul et al., 2013; Linsenbardt et
al., 2014; Korinek et al., 2015), have been
shown to exhibit selective potentiation or
inhibition of NMDA receptor-mediated
currents. Most of these compounds
appear to upregulate or downregulate
channel open probability; however, the
molecular interactions that underlie
modulation remain largely unknown. Indeed, for some of the compounds, it is not
Figure 1. Heteromeric subunit chimeras form functional NMDA receptor pores. A, Protein sequence at the five joints used to
construct the chimeric subunits in B. B, Simplified diagram of the four domains in two chimeric subunits of a heteromeric receptor
highlighting the pore loop and ␣ helical segments in the TMD derived from the GluN1 (blue) or GluN2 (red) subunit. Non-TMD
portions of each chimera derived from the GluK2 kainate receptor subunit are shown in black. Subunits with N1 and N2 extracellular
domains are presumed to be adjacent in functional tetramers. For clarity, the subunits are positioned opposite each other in the
diagram. C, Mean peak whole-cell agonist-evoked current (⫾ SEM) recorded at ⫺80 mV in HEK 293 cells transiently transfected
with chimeric subunit cDNAs and activated with either 10 M kainate (LBD from GluK2) or 10 M NMDA and 10 M glycine (LBDs
from NMDA receptor subunits). Agonist-evoked inward currents were significant (i.e., different from zero, t-statistic) for all of the
coexpressed construct combinations, but not for any of the chimeric constructs expressed alone. D, I–V for agonist-evoked current

4
recorded as the membrane potential was ramped from ⫺110
to ⫹60 mV at 0.75 mV ms ⫺1 in the presence (red) or absence
(black) of 1 mM external magnesium. All recordings from
GluN1/2B chimeras. Voltage axis ticks, 50 mV; current axis
ticks, 200 pA; except TMD, 500 pA.
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Table 1. Boltzmann parameters for voltage-dependent magnesium block
Construct
GluN2A
Wild type
TMD
LBD ⫹ TMD
ATD ⫹ LBD ⫹ TMD
TMD ⫹ CTD
LBD ⫹ TMD ⫹ CTD
GluN2B
Wild type
TMD
ATD ⫹ TMD
LBD ⫹ TMD
ATD ⫹ LBD ⫹ TMD
TMD ⫹ CTD
ATD ⫹ TMD ⫹ CTD
LBD ⫹ TMD ⫹ CTD

Slope

V1/2

#

14.7 ⫾ 1.2
16.7 ⫾ 1.3
15.3 ⫾ 0.4
14.6 ⫾ 0.3
17.1 ⫾ 1.2
13.7 ⫾ 0.3

⫺31.3 ⫾ 4.3
⫺20.2 ⫾ 2.6
⫺25.9 ⫾ 3.0
⫺25.9 ⫾ 6.8
⫺18.5 ⫾ 4.9
⫺6.7 ⫾ 1.6*

8
4
7
7
6
14

12.1 ⫾ 0.5
13.7 ⫾ 0.5
15.0 ⫾ 1.0
15.0 ⫾ 0.4
14.9 ⫾ 0.6
14.4 ⫾ 0.9
12.8 ⫾ 1.2
13.8 ⫾ 0.2

⫺16.8 ⫾ 1.5
⫺32.1 ⫾ 4.9
⫺18.1 ⫾ 5.2
⫺15.8 ⫾ 3.9
⫺18.5 ⫾ 1.9
⫺12.1 ⫾ 3.0
⫺21.6 ⫾ 4.0
⫺6.8 ⫾ 1.8*

16
14
6
15
3
3
3
14

Slope factors (k) and V1/2 values were obtained from best fits of a Boltzmann function: I ⫽ (a ⫹ Vm ) ⴱ 关b ⫹ c / (1 ⫹
exp关⫺(Vm ⫺ V1/2 )/k兴)兴 to I–V in the presence of 1 mM magnesium. Each GluN2 construct was coexpressed with the
homologous GluN1.1 construct. * denotes significant difference from wild type (ANOVA on ranks with post-hoc
Dunn’s test).

clear whether they bind to specific locations on the receptor or
exert an indirect influence on channel gating via changes in bulk
membrane properties (Casado and Ascher, 1998). Neurosteroids
have recently become a focus of drug development and together
with oxysterols and cis-unsaturated fatty acids may offer novel
targets for therapeutic intervention to reduce excessive NMDA
receptor activation.
In the present study we sought to determine which glutamate
receptor domains are required for NMDA receptor channel function and allosteric modulation. We generated a series of chimeric
subunits that swap domains between kainate receptor subunit
GluK2 and NMDA receptor subunits GluN1 and GluN2A or
GluN2B (Wilding et al., 2014). Our results show that the TMDs
from GluN1 and GluN2, together with the short linkers that connect to their respective LBDs, are sufficient to form functional
channels with characteristic features of NMDA receptors, including voltage-dependent block by magnesium and organic pore
blockers, permeability to calcium, and positive allosteric modulation by 24(S)-hydroxycholesterol [24(S)-HC; Paul et al., 2013].
In contrast, current potentiation by cis-unsaturated fatty acids
required additional membrane proximal portions of the cytoplasmic CTD, whereas potentiation by the neurosteroid pregnenolone sulfate (PS; Wu et al., 1991) was only observed in
chimeric receptors that included the LBD and TMD from NMDA
receptor subunits.

Materials and Methods
cDNA constructs, cell culture, and transfection. Rat subunit cDNAs were
generously provided by Steve Heinemann, Peter Seeburg, Mark Mayer,
Stefano Vicini, and Linda Nowak. Chimeric subunits were produced by a
restriction enzyme-free PCR cloning method (Tillett and Neilan, 1999)
or by ligation of PCR products with novel restriction sites inserted by
silent mutations. All constructs were sequenced by the Washington
University Protein Nucleic Acid Chemistry Laboratory. cDNAs were
expressed by transient transfection in HEK 293 cells using lipofectamine 2000 (Invitrogen). The cells were propagated in 25 cm 2
flasks with MEM plus 10% fetal bovine serum and passaged once each
week with protease XXIII (Sigma-Aldrich). Cells used for transfection
were seeded onto 12-well plates and transfected the following day.
Coexpression of GFP from a second vector was used to identify transfected cells. The day after transfection, cells were plated at low density
on 35 mm plates coated with nitrocellulose; recordings were obtained
on the following 2 d.

Electrophysiology. Cultures were bath perfused with Tyrode’s solution
containing the following (in mM): 150 NaCl, 4 KCl, 2 MgCl2, 2 CaCl2, 10
glucose, 10 HEPES, pH 7.4 with NaOH. Whole-cell electrodes were
pulled from borosilicate tubing (WPI) and filled with an internal solution that contained the following (in mM): 140 Cs-glucuronate, 10 EGTA,
5 CsCl, 5 MgCl2, 5 ATP, 1 GTP, and 10 HEPES, pH adjusted to 7.4 with
CsOH. Agonists and antagonists were delivered in control extracellular
solution (160 mM NaCl, 2 mM CaCl2, and 10 mM HEPES, pH adjusted to
7.4 with NaOH) by local perfusion from a multibarreled pipette positioned near the recorded cell. Currents were recorded with an Axopatch
200A amplifier controlled by p-Clamp software (Molecular Devices) and
are presented as mean ⫾ SEM agonist-evoked current (current during
agonist exposure minus holding current recorded in control solution
before and/or after agonist superfusion). Chimeras with LBDs from
GluK2 were treated with concanavalin A to increase steady-state agonist
responses for most experiments (Wilding et al., 2005).
Current–voltage relations (I–Vs) were generated by averaging the currents recorded during a series of five ascending and descending membrane potential ramps (0.75 mV ms ⫺1). I–Vs recorded in the presence of
magnesium were fit with a Boltzmann function: I ⫽ (a ⫹ Vm) ⴱ [b ⫹ c/
(1 ⫹ exp[⫺(Vm ⫺ V1/2)/k])] to compare the half-maximal voltage (V1/2)
and slope factor (k) for magnesium block. Statistical significance was
assigned for p ⬍ 0.05.
Molecular modeling. Homology modeling was performed in Modeler
(release 9.7; Eswar et al., 2008) using multiple templates (4PE5: Karakas
and Furukawa, 2014; 4TLM: Lee et al., 2014) and twofold symmetry
constraint for the A/C and B/D subunit pairs. Predictions for CTD secondary structure were made with JPred3 (Cole et al., 2008) and PEPFOLD (Thévenet et al., 2012), with subsequent loop-refinement in
Modeler.

Results
Chimeric channels with heteromeric NMDA receptor pores
To determine the structural requirements for allosteric modulation of receptors with NMDA receptor pore properties (Traynelis
et al., 2010; Huettner, 2015), we generated a number of chimeric
subunit constructs that replaced domains of GluN1, GluN2A,
and/or GluN2B with the homologous domain from the GluK2
kainate receptor subunit (Fig. 1 A, B). All of our initial chimeric
constructs contained the full NMDA receptor TMD, including
the transmembrane M4 helix and the linkers that connect the
TMD and LBD (Fig. 1 A, B). Agonist applications failed to evoke
significant current in HEK cells transfected with any of the chimeric subunits alone (Fig. 1C), indicating that they were unable
to form functional homomeric channels. However, cotransfection of GluN1 and GluN2 TMD-containing subunits together
resulted in substantial currents activated by the agonist(s) appropriate for the LBD: kainate for chimeric subunits that included
the LBD from GluK2 or NMDA and glycine for subunit combinations that contained the LBDs from GluN1 and GluN2 (Fig.
1C). Each functional combination of homologous constructs displayed voltage-dependent block by magnesium (Fig. 1D; Table
1), a characteristic feature of intact NMDA receptors (Mayer et
al., 1984; Nowak et al., 1984) mediated by adjacent asparagine
residues near the apex of the GluN2 subunit pore loop (Burnashev et al., 1992; Wollmuth et al., 1998). In addition, I–Vs recorded in normal and elevated calcium (2 and 10 mM) indicated
substantial calcium permeability for the chimeric receptors with
NMDA receptor pores (Fig. 2A). Based on the change in reversal
potential between the two external solutions of 7.5 ⫾ 0.5 mV
(n ⫽ 72), the permeability ratio for calcium to sodium (PCa/PNa)
was estimated at 4.4 ⫾ 0.4, which is consistent with previous
work on recombinant wild-type receptors (Jatzke et al., 2002).
Finally, chimeric receptors displayed voltage-dependent inhibition by ketamine (Fig. 2B), one of several organic blockers that
can be trapped within the closed NMDA receptor channel

8818 • J. Neurosci., August 24, 2016 • 36(34):8815– 8825

Wilding et al. • Allosteric Modulation of Chimeric Glutamate Receptors

(Traynelis et al., 2010). Block by 30 M
ketamine was essentially complete at ⫺80
mV (99.8 ⫾ 2.3%, n ⫽ 90) but substantially weaker at ⫹40 mV (65.5 ⫾ 4.9%,
n ⫽ 11). In addition, the potency of ketamine block was similar for wild-type
NMDA receptors and constructs in which
only the TMD and linkers came from
NMDA receptors (Fig. 2C,D). Thus, the
results in Figures 1 and 2 indicate that the
TMD and linker regions from the GluN1
and GluN2 subunits are together sufficient to specify formation of a functional
NMDA receptor pore. These results complement our earlier work (Wilding et al.,
2014), which showed that chimeric subunits with the TMD and linkers from
GluK2 transplanted into either GluN1 or
GluN2B fail to function as homotetramers but form functional heteromeric
channels with kainate receptor pore properties upon coexpression. Together, these
experiments support the idea that determinants for NMDA receptor subunit
heteromerization are distributed across
multiple iGluR domains (Ayalon and
Stern-Bach, 2001).
Domain requirements for positive
allosteric modulation
NMDA receptor activity can be potentiated
by exposure to a number of different membrane-derived modulatory compounds including AA and DHA (Miller et al., 1992; Figure 2. Calcium permeability and ketamine block of chimeric channels. A, Whole-cell current evoked by 10 M NMDA plus 10
Nishikawa et al., 1994), 24(S)-HC (Paul et M glycine as a function of voltage as membrane potential was ramped from ⫺110 to ⫹60 mV at 0.75 mV ms ⫺1 in 160 mM NaCl,
al., 2013), and PS (Wu et al., 1991). To eval- 10 mM HEPES with 2 mM CaCl2 (black), or with 10 mM CaCl2 (green), or with 2 mM CaCl2 and 1 mM MgCl2 (red). Note the rightward
uate the structural basis for this modulation, shift in reversal potential in elevated calcium. GluN1/2A TMD. B, Exposure to 30 M ketamine (black bars) blocks current evoked by
we recorded from HEK cells transfected 10 M kainate (open bars) at ⫺80 mV, and to a lesser extent at ⫹40 mV. GluN1/2A TMD. C, Whole-cell current evoked by 10 M
with chimeric subunits and compared the kainate is blocked progressively by 1, 3, 10, and 30 M katamine. GluN1/2A TMD. D, Current in the presence of ketamine as a
amplitude of agonist-evoked currents be- fraction of controln (mean ⫾ SEM) is plotted as a function of ketamine concentration. Smooth curves are best fits of 1/(1 ⫹
[(ketamine)/IC50] ) where IC50 is the concentration producing half-maximal inhibition and n is the slope factor. Values for chimeric
fore and immediately after exposure to constructs (N1/2A:
IC ⫽ 2.6 ⫾ 0.2, n ⫽ 1.9 ⫾ 0.3, 7 cells; N1/2B: IC ⫽ 1.7 ⫾ 0.1, n ⫽ 2.0 ⫾ 0.3, 9 cells) were not significantly
24(S)-HC (Fig. 3), PS (Fig. 4), or DHA different from those 50of the respective wild-type subunits (N1/2A: IC 50⫽ 2.0 ⫾ 0.1 M, n ⫽ 1.4 ⫾ 0.2, 13 cells; N1/2B: IC ⫽
50
50
(Fig. 5). As shown in Figure 3, ago- 1.6 ⫾ 0.2, n ⫽ 1.7 ⫾ 0.2, 10 cells) by t test.
nist-evoked whole-cell currents increased
following exposure to 24(S)-HC in heteronot potentiate currents mediated by edited or unedited GluK2
meric chimeric combinations that included the NMDA receptor
receptors. Importantly, exposure to PS did not cause significant
TMD, whereas treatment with 24(S)-HC had no effect on edited or
potentiation of currents mediated by the chimeric construct with
unedited homomeric wild-type GluK2 receptors or on heteromeric
NMDA receptor ATD and LBD fused to the TMD and CTD from
chimeric receptors with the extracellular ATD and LBD from
GluK2. Collectively, these results confirm earlier evidence that
NMDA receptors fused to the TMD and CTD from GluK2 (Wilding
interaction with the LBD is required for allosteric potentiation of
et al., 2014). Together, these results strongly suggest that the NMDA
NMDA receptor channels by PS. Additional portions of the linkreceptor TMD alone is necessary and sufficient to determine channel
ers and M4 helix may also be essential (Korinek et al., 2011;
modulation by 24(S)-HC.
Kostakis et al., 2011) as chimeric receptors that included the kaiIn contrast to 24(S)-HC, which potentiated constructs with an
nate receptor TMD and linkers were not potentiated by PS even
3),
PS
and
DHA
affected
distinct
NMDA receptor TMD (Fig.
when activated by NMDA and glycine binding to the NMDA
subsets of the chimeric receptors depending upon the presence of
receptor LBD.
additional NMDA receptor domains. Consistent with previous
Unlike PS and 24(S)-HC, exposure to AA and DHA moduevidence that potentiation by PS involves interaction with the
lates
activity of both NMDA and kainate receptors, potentiating
NMDA receptor LBD (Jang et al., 2004; Horak et al., 2006), we
NMDA-evoked currents in neurons (Miller et al., 1992) and inobserved substantial potentiation by PS of chimeric receptors
hibiting currents mediated by neuronal kainate receptors (Wildthat included both the TMD and LBD from NMDA receptor
ing et al., 1998). In addition, work on recombinant wild-type and
subunits (Fig. 4), but significantly less effect on chimeric conmutant or chimeric subunits indicates that the kainate receptor
structs that lacked the NMDA receptor LBD. In addition, PS did
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Figure 3. Potentiation by 24(S)-HC only requires the NMDA receptor TMD. A, Exposure to 10 M 24(S)-HC (shaded bar)
potentiated whole-cell current evoked by 10 M kainate (open bars) in an HEK cell transfected with the N1/N2B TMD chimera. B,
Minimal effect of 24(S)-HC on the N1/N2B ATD⫹LBD chimera activated by 10 M NMDA plus 10 M glycine. C, Plot of current
(mean ⫾ SEM) evoked after exposure to 24(S)-HC as a fraction of control current before 24(S)-HC treatment. *, Significant
difference from wild-type GluN1/2B was observed for homomeric GluK2 (Q or R) and for the N1/N2B ATD⫹LBD chimera, which has
an unedited (Q) kainate receptor TMD but not for chimeric constructs with the NMDA receptor LBD⫹TMD or TMD alone ( p ⬍
0.001, ANOVA on ranks with post hoc Dunn’s test).

Figure 4. PS potentiates chimeric channels that include the NMDA receptor LBD and TMD. A, B, Exposure to 100 M PS (shaded bar)
potentiateswhole-cellcurrentevokedby10 M NMDAplus10 M glycineinanHEKcelltransfectedwiththeN1/N2BLBD⫹TMDchimeric
subunits(A),butnotinacelltransfectedwiththeN1/N2BTMD-alonechimera(B).C,Plotofcurrent(mean⫾SEM)evokedduringexposure
to PS as a fraction of control current before PS treatment. *, Significant difference from wild-type GluN1/2B was observed for homomeric
GluK2 (Q or R), for heteromeric chimeras with the N1/2B TMD and linkers without the LBD and for the N1/N2B ATD⫹LBD chimera, which
has an unedited (Q) kainate receptor TMD; however, potentiation for the chimeric construct with the NMDA receptor LBD⫹TMD was not
significantly different from N1/2B. (p ⬍ 0.001, ANOVA on ranks with post hoc Dunn’s test).

J. Neurosci., August 24, 2016 • 36(34):8815– 8825 • 8819

TMD is sufficient to determine the effect
of DHA exposure on pore operation
(Wilding et al., 2014). Strong inhibition of
GluK2 by DHA requires the presence of
arginine at the glutamine/arginine (Q/R)
editing site of all four subunits in the tetramer, both for wild-type full-length homomeric GluK2 (Wilding et al., 2005) and
for chimeric receptors with the GluK2
TMD (Wilding et al., 2014). Moreover, an
M3 helix Leu to Ala substitution at the
level of the central cavity converts inhibition of edited (R) channels to potentiation, both for full-length GluK2(R)
(Lopez et al., 2013) and for chimeric channels that include the TMD and linker segments from GluK2 combined with the
ATD and LBD from NMDA receptor
subunits (Wilding et al., 2014). In sharp
contrast to the evidence that DHA modulation targets the kainate receptor TMD,
potentiation of NMDA receptor channels
by DHA was only observed for chimeric
constructs that included both the TMD
and CTD from NMDA receptors. As
shown in Figure 5, exposure to DHA had
no significant effect on constructs in
which the CTDs of both the GluN1 and
GluN2 subunits were replaced with the
GluK2 CTD but potentiated currents
mediated by constructs that included
both the TMD and CTD from NMDA receptors.
Requirement for membrane proximal
portions of the GluN2 CTD
To rule out the possibility that elements
within the GluK2 CTD might be incompatible with NMDA receptor channel potentiation by DHA, we generated deletion
constructs with stop codons immediately
after M4 corresponding to position K841
in GluN1 and R846 or R847 in GluN2A or
GluN2B, respectively. As shown in Figure
6 A, C, currents evoked by NMDA and
glycine in cells cotransfected with both
deletion constructs, or either deletion
construct together with a full-length partner, were unaffected by exposure to DHA,
suggesting a requirement for both NMDA
receptor CTDs. However, we also tested
combinations in which only the GluN1
CTD or only the GluN2 CTD was replaced
with the kainate receptor CTD from
GluK2 (Fig. 6 B, C). DHA potentiated receptors that included full-length GluN2A
or GluN2B together with chimeric GluN1
bearing the CTD from GluK2, albeit to a
lesser extent than completely wild-type
receptors. In contrast, DHA had no effect on receptors comprising full-length
GluN1 paired with chimeric GluN2A or
GluN2B subunits bearing the GluK2 CTD
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respectively (Fig. 7A–C). Weaker potentiation was also observed
for more proximal truncation after residue 877 of GluN2A or 878
of GluN2B, but not for several additional truncations closer to
M4 (Fig. 7A–C; data not shown). These results suggest that the
proximal GluN2 CTD is necessary for NMDA receptor potentiation by DHA. Our previous work (Wilding et al., 2014) indicated that kainate receptor modulation by DHA was similar for
wild-type GluK2 and for chimeric receptors with a TMD from
GluK2, heteromeric ATD and LBD from NMDA receptors, and
either the GluK2 CTD or heteromeric NMDA receptor CTDs. In
the present study we also tested whether the proximal GluN2
CTD alone was sufficient to modify the effect of DHA on homomeric edited (R) or unedited (Q) GluK2. As shown in Figure 7D,
DHA inhibition of GluK2(R) was unchanged by substitution of
the GluN2B CTD. Wild-type GluK2(Q) is unaffected by DHA,
whereas receptors substituted with the GluN2B CTD were weakly
inhibited. Collectively, these results suggest that the GluN2 proximal CTD renders the NMDA receptor TMD susceptible to potentiation by DHA, but has minimal effect on the GluK2 TMD.

Figure 5. DHA potentiates chimeric channels that include the NMDA receptor TMD and CTD.
A, Exposure to 15 M DHA (shaded bar) potentiated whole-cell current evoked by 10 M
kainate (open bars) in an HEK cell transfected with the N1/N2B TMD⫹CTD chimera. B, Lack of
effect of DHA on the N1/N2B TMD chimera. C, Plot of current (mean ⫾ SEM) evoked immediately after exposure to DHA as a fraction of control current before DHA treatment. *, Significant
potentiation for chimeric constructs with the NMDA receptor TMD⫹CTD, but not for chimeras
that included the NMDA receptor TMD and linkers without the CTD ( p ⬍ 0.05, Mann–Whitney
rank-sum tests).

(Fig. 6 B, C). Together, these results indicate that fatty-acid potentiation requires the GluN2 CTD, but on the GluN1 subunit
either the native wild-type CTD or the GluK2 CTD will suffice.
Additional deletion mutants were created to determine which
portion of the GluN2 CTD was essential. Potentiation was maintained with truncation after position 931 in either GluN2A or
GluN2B, resulting in deletion of the C-terminal 526 or 544 aa,

Cysteine replacement in the proximal CTD reduces
potentiation by DHA
Previous biochemical studies have identified a number of posttranslational modification sites within the minimal essential region of the GluN2 CTD identified in Figure 7, including a cluster
of cysteine residues that can undergo palmitoylation (Hayashi et
al., 2009; Mattison et al., 2012) and a conserved tyrosine that may
be phosphorylated by Src kinase (Vissel et al., 2001). As an initial
test for whether any of these potential modification sites are required for allosteric modulation by DHA, we generated mutant
versions of GluN2A and GluN2B with Y-to-F substitution at the
conserved tyrosine and C-to-A substitution at all three of the
proximal cysteines. An additional cysteine (C838) located near
the cytoplasmic end of M4 in GluN2B was substituted with Trp,
the residue at the homologous position in GluN2A. As shown in
Figure 8, full-length receptors bearing all of these substitutions
were unaffected by exposure to DHA. Additional mutant fulllength GluN2A constructs revealed that potentiation by DHA
was reduced relative to wild-type for all of the single, double, or
triple substitutions in the proximal cysteine cluster, but was least
affected for the Y842F substitution, which exhibited significant
increases in agonist-gated current after DHA exposure (Fig.
8 A, B). Together, these results strengthen the evidence for involvement of the proximal CTD in allosteric modulation by DHA
and raise the possibility that cysteine modification could be a
contributory factor.
Although there is no x-ray crystal structure available for any of
the iGluR CTDs, algorithms that predict secondary structure suggest that there may be several ␣ helical segments within the proximal CTD of each iGluR subunit (Ryan et al., 2008). The minimal
GluN2 cytoplasmic domain essential for DHA potentiation includes a predicted helical region between C2 and C3 that encompasses a conserved SRGIYSC sequence (Fig. 7A) that is present in
all four GluN2 subunits. Although the helical properties of this
proximal CTD segment require structural confirmation, together
our results suggest a hypothetical model for the GluN2 proximal
CTD shown in Figure 9.

Discussion
Our results support several conclusions about iGluR structure,
operation, and regulation by positive allosteric modulators. First,
we show that GluN1 and GluN2 subunit TMDs and linkers include sufficient constraints for the assembly of functional hetero-
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Functional NMDA/kainate receptor
subunit chimeras
Although much remains to be learned
about specification of specific subunit
combinations, there is growing evidence
that several distinct domain interactions contribute to production of heteromeric iGluRs (Traynelis et al., 2010;
Herguedas et al., 2013). For NMDA receptors, assembly as obligate heterotetramers is thought to involve initial
association controlled by the extracellular ATDs (Hansen et al., 2010). Indeed,
our earlier work showed that chimeric
subunits with the extracellular domains
from NMDA receptors and a transmembrane and cytoplasmic portion from
GluK2 kainate receptors fail to function
as homotetramers but only form functional channels when coexpressed as
N1/K2⫹N2B/K2 heteromers (Wilding
et al., 2014). Thus, NMDA receptor extracellular domains are sufficient to
impose a requirement for heteromerization onto the kainate receptor pore
(Wilding et al., 2014), despite the fact
that native full-length GluK2 forms
functional homotetramers (Egebjerg et
al., 1991).
In this study we found that interactions promoting heteromerization are
also present within the NMDA receptor
TMD and linkers (Ayalon and SternBach, 2001). Previous work (Villmann et
Figure 6. DHA potentiation requires the GluN2 CTD. A, Exposure to 15 M DHA (shaded bars) did not potentiate whole-cell
al., 1999; Liu and Nowak, 2000) showed
currents evoked by 10 M NMDA plus 10 M glycine (open bars) in HEK cells cotransfected with truncated GluN1840 and GluN2B846
that
chimeric subunits in which only the
(top trace), or for cotransfection of a wild-type and a truncated subunit: GluN1840/GluN2Bwt (middle trace), GluN1wt/GluN2B846
M1–M3
pore domain from GluN1 was
(bottom trace). B, Exposure to 15 M DHA (shaded bar) potentiated whole-cell current evoked by 10 M NMDA plus 10 M glycine
(open bars) in an HEK cell transfected with a GluN1 chimera bearing a GluK2 CTD and wild-type GluN2B (top); lack of effect of DHA transplanted into GluK2 formed funcon wild-type GluN1 with the GluN2B chimera bearing a GluK2 CTD (bottom). C, Plot of current (mean ⫾ SEM) evoked immediately tional homomeric channels that were
after exposure to DHA as a fraction of control current before DHA treatment for wild-type and truncated or chimeric NMDA receptor activated by kainate, suggesting the hosubunits. *, Significant difference from wild-type ( p ⬍ 0.0001, ANOVA on ranks with post hoc Dunn’s test) and not significantly momeric extracellular domains from
different from no effect (i.e., IDHA/Icontrol ⫽ 1, t-statistic). # denotes that for the N1 (K2CTD)/N2 wild-type combinations IDHA/Icontrol GluK2 enabled assembly of a chimeric
was significantly ⬎1 but also significantly less than that for wild-type receptors. Inset, Proximal CTD sequences of GluN1, GluN2A, pore. However, similar constructs using
and GluN2B. Shading denotes truncation after N1 H840, 2A L845, and 2B F846.
M1–M3 from GluN2B failed to function
as homomeric channels or when coexpressed with GluN1 pore-domain chimemeric tetramers. Chimeric subunits that included GluN1 or
ras (Villmann et al., 2008). Moreover, chimeric GluN1 M1–M3
GluN2 TMDs and linkers failed to generate functional channels
homomers lacked characteristic NMDA receptor features
when expressed alone, but heteromeric coexpression gave rise to
(Villmann et al., 1999), including voltage-dependent magnesium
robust agonist-gated currents that displayed signature features of
and MK-801 block, properties preserved in our constructs that
NMDA receptor pores, including permeability to calcium and
swap the entire TMD including linkers to the LBD and the M4
voltage-dependent block by magnesium and ketamine (Traynelis
helix. Previous studies have highlighted the importance of the M4
et al., 2010). Second, we demonstrate distinct domain requirehelix for iGluR assembly and function (Schorge and Colquhoun,
ments for positive allosteric modulation by three membrane2003; Terhag et al., 2010; Salussolia et al., 2013). In addition,
derived regulators. The cholesterol metabolite 24(S)-HC had no
recent NMDA receptor crystal structures (Karakas and Furueffect on homomeric GluK2 but strongly potentiated chimeric
kawa,
2014; Lee et al., 2014) confirm extensive contact between
channels that included the TMD and linkers from NMDA recepGluN1
and GluN2 involving the M4 helix of each subunit with
tor subunits. Potentiation by the neurosteroid PS required both
M1
and
M3 helices of the adjacent heteromeric subunit. Our
the LBD and TMD from NMDA receptors, confirming earlier
results suggest that this M4-mediated contact is sufficient to almutation studies (Jang et al., 2004; Horak et al., 2006). In conlow for heteromeric association of the M1–M3 pore domain into
trast, potentiation by DHA did not require the NMDA receptor
functional channels sensitive to magnesium and ketamine as exLBD but was only observed for chimeric channels that included a
proximal portion of the GluN2 subunit CTD.
pected for native NMDA receptors.
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Domain requirements for positive
allosteric modulation
In addition to competitive antagonists and
channel blockers, a diverse assortment of allosteric regulators have been shown to modify the operation of NMDA receptors,
including endogenous molecules, such as
polyamines, zinc, fatty acids, lysophospholipids, and cholesterol metabolites, as well as
a growing repertoire of synthetic compounds (Collingridge et al., 2013; Zhu and
Paoletti, 2015). Binding sites and mechanisms of modulation have been proposed
for a number of these allosteric modulators
(Zhu and Paoletti, 2015), but in many cases
the basis for regulation remains incompletely understood. Our results using chimeric subunits to evaluate three positive
allosteric modulators derived from components of the lipid bilayer revealed three distinct domain requirements: PS (Jang et al.,
2004; Horak et al., 2006) required the
NMDA receptor LBD and TMD, whereas
24(S)-HC potentiated chimeras that only
included the TMD and linkers from NMDA
receptors combined with the ATD, LBD,
and CTD from GluK2. Recent work suggests that 24(S)-HC (Paul et al., 2013) acts
by a different mechanism than either PS or
cis-unsaturated fatty acids as potentiation by
24(S)-HC does not occlude modulation by
PS or AA. In addition, the 25-hydroxy derivative of cholesterol noncompetitively reduces potentiation by 24(S)-HC but does
not prevent potentiation by PS or AA (Linsenbardt et al., 2014). Thus, our results suggesting distinct structural requirements for
allosteric modulation are broadly consistent with recent analysis of oxysterol
pharmacology.
The finding that potentiation by fatty
acid exposure requires a proximal segment of the GluN2 CTD was not expected. Our recent work on chimeric
receptors with kainate receptor pores revealed that DHA produced similar modu- Figure 7. The GluN2 proximal CTD supports NMDA receptor TMD potentiation. A, Sequence of the GluN1.1 CTD (blue) noting
lation of the GluK2 TMD and linkers joints for the C0, C1, and C2 splice cassettes; alignment of the membrane-proximal portions of GluN2A (green) and GluN2B (red)
regardless whether the CTD came from noting location of conserved Tyr (Y) and Cys (C1, 2, 3) residues. B, Exposure to 15 M DHA (shaded bar) did not potentiate
whole-cell current evoked by 10 M NMDA plus 10 M glycine (open bars) in HEK cells cotransfected with wild-type GluN1.1 and
GluK2 or from GluN1/2B (Wilding et al.,
GluN2B truncated after S870 (top trace), but did potentiate for N2B truncation after E878 (middle trace) or V931 (bottom trace). C,
2014). In addition, earlier work by Casado Plot of current (mean ⫾ SEM) evoked immediately after exposure to DHA as a fraction of control current before DHA treatment for
and Ascher (1998) had suggested that wild-type and GluN2 truncated NMDA receptors. *, Significant difference from wild-type ( p ⬍ 0.0001, ANOVA on ranks with post
NMDA receptor modulation by AA and hoc Dunn’s test) and not significant difference from no effect (I /I
DHA control ⫽ 1, t-statistic). # denotes that for the other N2
lysophospholipids, as well as mechano- truncations IDHA/I control was significantly ⬎1 but also significantly less than for wild-type receptors. D, Exposure to 15 M DHA
sensitivity (Paoletti and Ascher, 1994), did (shaded bar) inhibited whole-cell current evoked by 10 M kainate (open bars) in an HEK cell transfected with chimeric GluK2(R)
not involve the CTD. They showed that bearing a CTD from GluN2B. Plot of current (mean ⫾ SEM) evoked at the end of DHA exposure as a fraction of control current before
channel modulation by mechanical defor- DHA treatment. *, DHA produced weak but significant ( p ⫽ 0.030) inhibition of unedited (Q) chimeric GluK2 subunits and strong
mation of the membrane was preserved in inhibition of edited (R) chimeric receptors that was not different from wild-type GluK2(R) ( p ⫽ 0.148). Inset, Proximal CTD
truncated mutants lacking either the sequences of GluK2 and GluN2B indicating the position of the K2/2B joint.
GluN1 CTD or the distal CTD of GluN2A
(Casado and Ascher, 1998). In addition, modulation by lyso(terminated at residue 1082 or 1438). Channel inhibition by lyphospholipids was only observed with extracellular application.
sophosphatidyl inositol persisted in receptors with proximal
Several groups have reported consistent potentiation of NMDA
GluN2A CTD truncation at position 844; however, the effect on
receptors by AA or DHA applied to outside-out patches (Miller et
mechanosensitivity or potentiation by AA was not reported
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philic molecules often appear inactive
when delivered by intracellular dialysis
from the electrode (Jo and Bean, 2014).
Our results in the present study do confirm earlier evidence that anchorage to cytoplasmic scaffolding proteins by the
GluN2 distal C terminus is not essential
for modulation (Casado and Ascher,
1998), but they also reveal an absolute requirement for the GluN2 proximal CTD
in potentiation by DHA. Further work
will be needed to determine the exact relationship between mechanosensitivity
and allosteric regulation by fatty acids,
lysophospholipids, oxysterols, or other lipophilic modulators.
Previous work identified several posttranslational modifications within the
proximal CTD of GluN2A and GluN2B,
Figure 8. Proximal GluN2 CTD substitutions prevent DHA potentiation. A, Plot of current (mean ⫾ SEM) evoked immediately
including tyrosine phosphorylation near
after exposure to DHA as a fraction of control current before DHA treatment for NMDA receptors with wild-type GluN1 and the
indicated substitutions to full-length GluN2. Residues highlighted in yellow are wild-type. *, Significant difference from wild-type the cytoplasmic end of M4 (Vissel et al.,
( p ⬍ 0.0001, ANOVA on ranks with post hoc Dunn’s test) and not significant difference from no effect (IDHA/Icontrol ⫽ 1, t-statistic). 2001) and palmitoylation of three con# denotes that for the N1 wt/N2A Y842F combination IDHA/Icontrol was significantly ⬎1 but also significantly less than for wild-type served cysteine residues within the first
receptors. B, Traces show the quadruple FAAA mutant lacked potentiation by DHA (top trace). Potentiation was preserved for the 30 – 40 CTD amino acids (Hayashi et al.,
Y842F substitution, in some cases reaching the level observed for wild-type receptors (bottom trace).
2009). All of these modifications have
been implicated in the regulation of receptor trafficking: the tyrosine residue is
part of consensus binding motif for the
clathrin adaptor protein AP-2 present in
all four GluN2 subunits (Scott et al.,
2004). Phosphorylation of this Tyr stabilizes receptors at the surface but is suppressed by serine substitution at the three
proximal Cys residues of either GluN2A
or GluN2B. Thus, modification of proximal cysteines by palmitate thioesterification has been suggested to reduce NMDA
receptor internalization by enhancing
phosphotyrosine levels (Hayashi et al.,
2009). Because robust potentiation by AA
(Casado and Ascher, 1998) or DHA (Nishikawa et al., 1994) persists in outsideout patches, it is likely to involve a direct
allosteric effect rather than a change in receptor trafficking to and from the surface
membrane (Linsenbardt et al., 2014). Indeed, our results in the present study
indicate that allosteric potentiation by cisunsaturated fatty acids depends on the
three proximal cysteine residues but does
Figure 9. NMDA receptor model with GluN2A proximal CTD. Homology model for GluN1/GluN2A generated by Modeler (Eswar
et al., 2008) using PDB files 4PE5 (Karakas and Furukawa, 2014) and 4TLM (Lee et al., 2014) as templates and with twofold not require the conserved tyrosine that disymmetry constraint for the A/C and B/D subunits. Prediction for the proximal CTD generated by PEP-FOLD (Thévenet et al., 2012) rectly regulates internalization.
In summary, our study demonstrates
with subsequent loop-refinement in Modeler. Palmitoylation at C1, 2, and 3 is expected to tether the proximal CTD to the
formation of functional heteromeric
membrane.
NMDA receptor pores by chimeric subunits constructed by replacing intracelal., 1992; Nishikawa et al., 1994), but also in at least one experilular and extracellular portions of GluN1, GluN2A, and
ment on inside-out patches with exposure from the cytoplasmic
GluN2B with homologous segments from kainate receptor
side (Casado and Ascher, 1998). We have not had success with
subunit GluK2. In addition, we demonstrate that distinct
inside-out recordings from chimeric channels with NMDA reNMDA receptor domains underlie positive allosteric modulaceptor CTDs, possibly because of their relatively low expression
tion by PS, 24(S)-hydroxycholesterol, and DHA. Although
(Fig. 1C), nor have we attempted to elicit modulation in wholefurther work will be needed to understand the detailed mechcell recordings by adding DHA to the internal solution, as lipoanisms that underlie channel regulation, one possible inter-
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pretation is that our results implicate regions where each of
the modulators directly interacts with the receptor. Alternately, these domains may be required for sensing specific
changes in membrane mechanical properties or contacting
other structural elements necessary for indirect modulation.
Our results with DHA identify an unexpected requirement for
three conserved cysteine residues in the proximal cytoplasmic
tail, suggesting that palmitoylation of these cysteines may be
important for fatty acid modulation. Establishing where and
how endogenous allosteric modulators act should facilitate
ongoing efforts (Collingridge et al., 2013; Zhu and Paoletti,
2015) to identify more potent and selective drugs capable of
upregulating or downregulating specific iGluR subpopulations (Paoletti et al., 2013).
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